德国拜耳拜瑞妥怎么买？

Sold under the trade name Xarelto by Bayer of Germany, it is an anticoagulant drug (blood thinner) used to treat and prevent blood clots. It is used to treat venous thrombosis (DVT) in adults and reduce the risk of DVT recurrence and pulmonary embolism (PE) after acute DVT.

EINSTEIN-Jr is a randomized, open-label Phase III study enrolling 500 pediatric patients (birth to 17 years) diagnosed with acute VTE who were initiated on heparin therapy. Pediatric patients received open-label, weight-adjusted dose Xarelto (n = 335, tablet or suspension) or standard anticoagulant therapy (n = 165, unfractionated heparin, low-molecular-weight heparin, fondaparinux, or a switch to a vitamin K antagonist) in a 2:1 ratio. The treatment period is 3 months, except for children under 2 years of age with catheter-related VTE who receive 1 month of treatment. Repeat imaging was performed at the end of treatment. The results showed that the study met all pre-specified endpoints: recurrent VTE events were similar in the 2 groups, and slightly lower in the rivaroxaban (Xarelto) treatment group (recurrent VTE event rate: 1.2% [n=4] vs 3.0% [n=5]; HR=0.40, 95%CI: 0.11-1.41), and there were no fatal VTE events in either treatment group.

How to buy Bayer Xarelto in Germany?

Bayer announced that its new oral anticoagulant (rivaroxaban) has been launched in China as a single-drug treatment for pulmonary embolism. Patients can purchase it with a prescription, or they can purchase the drug from domestic overseas medical service institutions.

Recommended related hot articles: /newsDetail/92108.html